Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

ALS (ALQ.AX)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (A$)	Price Target (A$)	Rating
2022-02-11	12.30	13.50	Neutral
2022-03-01	12.38	13.30	Neutral
2022-05-25	12.01	13.10	Neutral
2022-08-23	12.00	13.15	Neutral
2022-11-18	12.17	13.25	Neutral
2023-03-20	11.23	12.30	Neutral
2023-05-24	12.40	12.70	Neutral
2023-05-29	11.75	12.10	Neutral
2023-11-17	12.14	13.00	Neutral
2024-03-25	13.07	13.30	Neutral
2024-05-21	14.48	14.55	Neutral
2024-07-19	14.38	17.00	Buy
2024-09-19	13.67	16.30	Buy
2024-11-19	15.50	17.50	Buy
2025-04-28	16.36	18.70	Buy

Disclosures

UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.